These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37270812)

  • 1. RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions.
    Gelain DP; Bittencourt RR; Bastos Mendes LF; Moreira JCF; Outeiro TF
    J Parkinsons Dis; 2023; 13(5):717-728. PubMed ID: 37270812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
    König A; Vicente Miranda H; Outeiro TF
    J Parkinsons Dis; 2018; 8(1):33-43. PubMed ID: 29480231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia.
    Long H; Zhang S; Zeng S; Tong Y; Liu J; Liu C; Li D
    Cell Rep; 2022 Sep; 40(12):111401. PubMed ID: 36130498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
    Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
    Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of striatal astrocytic receptor for advanced glycation end-products variants in an early stage of experimental Parkinson's disease.
    Viana SD; Valero J; Rodrigues-Santos P; Couceiro P; Silva AM; Carvalho F; Ali SF; Fontes-Ribeiro CA; Pereira FC
    J Neurochem; 2016 Aug; 138(4):598-609. PubMed ID: 27221633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.
    Gadhe L; Sakunthala A; Mukherjee S; Gahlot N; Bera R; Sawner AS; Kadu P; Maji SK
    Biophys Chem; 2022 Feb; 281():106736. PubMed ID: 34923391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The link between neuroinflammation and the neurovascular unit in synucleinopathies.
    Wang Q; Zheng J; Pettersson S; Reynolds R; Tan EK
    Sci Adv; 2023 Feb; 9(7):eabq1141. PubMed ID: 36791205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational modification of lysine residues in erythrocyte α-synuclein.
    Amagai R; Yoshioka S; Otomo R; Nagano H; Hashimoto N; Sakakibara R; Tanaka T; Okado-Matsumoto A
    J Biochem; 2023 Mar; 173(3):177-184. PubMed ID: 36469357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments.
    Bosbach C; Gatzemeier LM; Bloch von Blottnitz KI; König A; Diederichsen U; Steinem C; Outeiro TF
    Org Biomol Chem; 2024 Mar; 22(13):2670-2676. PubMed ID: 38483440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.
    Gasparotto J; Somensi N; Girardi CS; Bittencourt RR; de Oliveira LM; Hoefel LP; Scheibel IM; Peixoto DO; Moreira JCF; Outeiro TF; Gelain DP
    J Neurochem; 2023 Jun; ():. PubMed ID: 37381043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
    Vicente Miranda H; Szego ÉM; Oliveira LMA; Breda C; Darendelioglu E; de Oliveira RM; Ferreira DG; Gomes MA; Rott R; Oliveira M; Munari F; Enguita FJ; Simões T; Rodrigues EF; Heinrich M; Martins IC; Zamolo I; Riess O; Cordeiro C; Ponces-Freire A; Lashuel HA; Santos NC; Lopes LV; Xiang W; Jovin TM; Penque D; Engelender S; Zweckstetter M; Klucken J; Giorgini F; Quintas A; Outeiro TF
    Brain; 2017 May; 140(5):1399-1419. PubMed ID: 28398476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.
    Guerrero E; Vasudevaraju P; Hegde ML; Britton GB; Rao KS
    Mol Neurobiol; 2013 Apr; 47(2):525-36. PubMed ID: 22923367
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Granek Z; Barczuk J; Siwecka N; Rozpędek-Kamińska W; Kucharska E; Majsterek I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson's disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy.
    Kim J; Han JY; Lee Y; Kim K; Choi YP; Chae S; Hoe HS
    Mol Brain; 2023 Jan; 16(1):7. PubMed ID: 36647152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
    Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
    Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson's Disease.
    Battis K; Xiang W; Winkler J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.